| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/16/2008 | EP1942920A1 Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same |
| 07/16/2008 | EP1942900A2 Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting kinases methods for inhibiting protein kinases |
| 07/16/2008 | EP1942897A1 Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 07/16/2008 | EP1942891A1 Novel combination of drugs as antidepressant |
| 07/16/2008 | EP1942885A1 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors |
| 07/16/2008 | EP1942880A1 A combination of cannabinoids for the treatment of peripheral neurophatic pain |
| 07/16/2008 | EP1942879A1 Gaba receptor mediated modulation of neurogenesis |
| 07/16/2008 | EP1689737B1 Beta-lactams for the treatment of cns disorders |
| 07/16/2008 | EP1620439B1 New polymorphs of olanzapine hydrochloride |
| 07/16/2008 | EP1603577B1 Compounds for the treatment of pain |
| 07/16/2008 | EP1581492B1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 07/16/2008 | EP1506205B1 Novel azacyclic ethynyl derivatives |
| 07/16/2008 | EP1476151B1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders |
| 07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
| 07/16/2008 | EP1446104B1 Spray drying methods |
| 07/16/2008 | EP1426051B1 Medicinal composition for prevention of or treatment for cerebrovascular disorder |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | EP1392264B1 Delivery of antiemetics through an inhalation route |
| 07/16/2008 | EP1392257B1 Delivery of antihistamines through an inhalation route |
| 07/16/2008 | EP1390491B1 Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors |
| 07/16/2008 | EP1390372B1 1-oxa-3,9-diaza-spiro'5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/16/2008 | EP1379882B1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders |
| 07/16/2008 | EP1326849B1 Benzodiazepine derivatives as inhibitors of gamma secretase |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | EP1178789B1 Method of treating eating disorders |
| 07/16/2008 | EP1090122B1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 07/16/2008 | CN201085837Y Sleeping pillow for pacifying the mind |
| 07/16/2008 | CN101223187A New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 07/16/2008 | CN101223178A Therapeutic agents |
| 07/16/2008 | CN101223168A Heterocyclic JANUS kinase 3 inhibitors |
| 07/16/2008 | CN101223163A New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 07/16/2008 | CN101223159A Pyrazole derivatives as CBI modulators |
| 07/16/2008 | CN101223142A Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 07/16/2008 | CN101222919A Combination of a DPP-iv inhibitor and a cannabinoid CB1 receptor antagonist |
| 07/16/2008 | CN101222918A Methods and compositions for the treatment of pain |
| 07/16/2008 | CN101222916A Phenol derivatives and their use to modulate PKB activity |
| 07/16/2008 | CN101220360A SiRNA sequence restraining caspase-3 gene expression |
| 07/16/2008 | CN101220359A SiRNA sequence restraining bak gene expression |
| 07/16/2008 | CN101220089A Chinese South China sea signal conus neurotoxin gene Lt3.1 and uses thereof |
| 07/16/2008 | CN101220065A Novel scutellarin compounds and uses thereof |
| 07/16/2008 | CN101220064A Novel scutellaria glycosides compounds and uses thereof |
| 07/16/2008 | CN101220063A Novel method for preparing catalpol medicament composition containing the same and uses thereof |
| 07/16/2008 | CN101220043A Benzothiazolo [3, 2,-a]-miazine derivant and uses thereof |
| 07/16/2008 | CN101220028A Urea substituted imidazopyridines |
| 07/16/2008 | CN101220027A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 07/16/2008 | CN101220026A 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 07/16/2008 | CN101219963A Phenylcarbinol kearny ester compounds |
| 07/16/2008 | CN101219220A Remifentanil polymer sustained-release analgesic and its preparing process |
| 07/16/2008 | CN101219188A Anti-inflammation antalgica liquid |
| 07/16/2008 | CN101219187A Method for preparing Chinese medicine of condensed pill for preventing brain decline |
| 07/16/2008 | CN101219176A Externally used sleeping liquid |
| 07/16/2008 | CN101219170A Chinese medicine composition for treating alcoholic liver |
| 07/16/2008 | CN101219164A Traditional Chinese medicine preparation for treating sick headache |
| 07/16/2008 | CN100402543C Preparation method of hyperin and hypericin of Hypericum perforatum |
| 07/16/2008 | CN100402534C Tricycle compounds and its application in making medicine |
| 07/16/2008 | CN100402529C Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
| 07/16/2008 | CN100402515C Substituted phthalides as anti-convulsive drugs |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
| 07/16/2008 | CN100402064C Liver-protecting sobering-up capsule and method for preparing the same by utilizing grape peel |
| 07/16/2008 | CN100402036C Coating agent for treating insomnia and its usage |
| 07/16/2008 | CN100402032C Tetrahydroquinoline analogues as muscarinic agonists |
| 07/16/2008 | CN100402025C Modified release pharmaceutical formulation |
| 07/16/2008 | CN100402021C Delayed release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399829 Variants of RANKL protein |
| 07/15/2008 | US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease |
| 07/15/2008 | US7399774 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 07/15/2008 | US7399763 and highly specific HIV replication inhibitor; ethyl 2-benzyl-8-hydroxy-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2- alpha ]pyrazine-7-carboxylate; aquired immune deficiency syndrome (AIDS) |
| 07/15/2008 | US7399761 Phthalazine derivatives with angiogenesis inhibiting activity |
| 07/15/2008 | US7399759 1, 3-benzothiazinone derivatives and use thereof |
| 07/15/2008 | US7399756 Organo-phosphorous compounds for activating gamma/delta T cells |
| 07/15/2008 | US7399747 Peptides carrying substances across the blood brain barrier |
| 07/15/2008 | US7399472 Vaccines |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
| 07/15/2008 | US7399463 HSA-free formulations of interferon-beta |
| 07/15/2008 | CA2478980C Pulmonary delivery for levodopa |
| 07/15/2008 | CA2397942C Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation |
| 07/15/2008 | CA2348693C Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid |
| 07/15/2008 | CA2315258C Neuroprotective agents |
| 07/15/2008 | CA2298522C 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy |
| 07/15/2008 | CA2279620C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
| 07/15/2008 | CA2271857C Method for treating symptoms of diabetes |
| 07/15/2008 | CA2205557C Monofunctional and/or polyfunctional polylysine conjugates |
| 07/10/2008 | WO2008082003A1 Fused heterocyclic compounds having crf antagonistic activity |
| 07/10/2008 | WO2008081989A1 Nerve regeneration agent |
| 07/10/2008 | WO2008081934A1 Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same |
| 07/10/2008 | WO2008081774A1 Orally disintegrating tablet and bitter-blocking preparation each comprising risperidone |
| 07/10/2008 | WO2008081732A1 Animal model of schizophrenia or cognitive impairment, screening method using the same and preventive or therapeutic agent for schizophrenia or cognitive impairment |
| 07/10/2008 | WO2008081580A1 Analgesic agent comprising cyclic phosphatidic acid derivative |
| 07/10/2008 | WO2008081477A1 3-aryloxy 3-substituted propanamines |
| 07/10/2008 | WO2008081399A2 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 07/10/2008 | WO2008081041A2 Amorphous and crystalline forms of rivastigmine hydrogentartrate |
| 07/10/2008 | WO2008081013A1 Use of somatostatin analogs in cluster headache |
| 07/10/2008 | WO2008081012A1 Spiropiperidine derivatives as nk3 antagonists |
| 07/10/2008 | WO2008081008A1 Method of providing disease-specific binding molecules and targets |
| 07/10/2008 | WO2008080986A1 Furan derivatives, method of synthesis and uses thereof |
| 07/10/2008 | WO2008080973A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |